Careium (CARE) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
21 May, 2026Executive summary
Achieved solid growth and strong profitability in Q2 2024, with net sales rising 7.3% year-over-year to SEK 229.4 million and key innovation launches enhancing connectivity and service uptime.
Focus growth markets Germany and France delivered over 180% sales growth year-over-year, driven by updated EU market strategy.
Stable performance despite challenges from freight costs and infrastructure transition delays in the UK and Sweden.
Operating profit (EBIT) increased 48.9% to SEK 21.8 million, with an EBIT margin of 9.5%.
EBITDA margin improved to 16.4% from 15.4% in Q2 2023.
Financial highlights
Net sales reached SEK 229.4 million, up 7.3% organically year-over-year; adjusted for currency, growth was 6.8%.
Service sales increased 2.8% to SEK 163.3 million; product sales rose 20.5% to SEK 66.1 million.
Gross margin was 41.7%, slightly down from 42.2% due to higher freight costs and product mix.
Q2 net result: SEK 13.9 million (down 7.5%); Q2 EPS: SEK 0.54 (down 8.5%).
Free cash flow was SEK 0.5 million, down from SEK 7.7 million, mainly due to inventory build-up.
Outlook and guidance
Full-year guidance maintained: 12-15% organic growth with improved profitability versus 2023.
H1 2024 delivered 8% growth and 86% EBIT increase, supporting confidence in guidance.
Management remains committed to higher growth in H2, especially Q4.
Priorities include maximizing value from new innovations and converting UK sales pipeline.
Latest events from Careium
- Sales fell 7.2% in Q3, but solid margins and innovation support 2024 growth targets.CARE
Q3 202411 Jun 2026 - Strong sales, profit growth, and margin expansion set the stage for further gains in 2025.CARE
Q4 202411 Jun 2026 - Gross margin improved to 44.5% despite lower sales and profit, with growth outside Sweden.CARE
Q1 202511 Jun 2026 - Sales and profit fell, but gross margin and cash flow improved; outlook remains positive.CARE
Q2 202511 Jun 2026 - Net sales and profit rose, but margins declined due to investments and onboarding costs.CARE
Q1 20265 May 2026 - Q4 2025 delivered modest sales growth, lower EBIT, and stronger cash flow amid margin pressure.CARE
Q4 202516 Feb 2026 - Aging demographics fuel growth in care tech, with innovation and recurring revenue driving strategy.CARE
ABGSC Investor Days12 Jan 2026 - Q3 2025 delivered 6% sales growth, higher margins, and strong product sales despite one-off costs.CARE
Q3 202524 Oct 2025